Of eligible respondents, 72 percent agreed with the statement, “Medical marijuana should be used to reduce the use of opioids for non-cancer pain.” Sixty-three percent of respondents also agreed, “The DEA should reclassify marijuana so that it is no longer a schedule I drug.”